Maximilian K.
- Country
- Sweden
- Department
- Fas 1-enheten Solna, Centrum för Kliniska Cancerstudier (CKC), Tema Cancer
Research Overview
- Phase I Study of pTTL T Cell Immunotherapy in Patients with Advanced Colorectal Cancer
- Phase I Study of BI 3923948 Monotherapy and in Combination with an Anti-PD-1 Antibody in Patients with Advanced, Unresectable, or Metastatic Solid Tumors
- Safety Study of Ivosidenib in Patients with Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
Data & Insights
Has run more than one trial at 51 of 138 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced forms of gastrointestinal cancers, with particular emphasis on pancreatic ductal adenocarcinoma and colorectal cancer.
- Pancreatic Cancer Treatment Innovations
- Colorectal Cancer Immunotherapy
- Advanced Treatment Protocols
Their work includes evaluation of combination therapeutic approaches and novel immunotherapy treatments.
Hepatobiliary Oncology
The investigator focuses on the treatment of cholangiocarcinoma, particularly in its advanced and metastatic forms, exploring innovative therapeutic approaches for bile duct cancers.
- Biliary Tract Cancer Management
- Advanced Stage Treatment Protocols
- Targeted Therapy Applications
Their expertise extends to managing locally advanced and metastatic manifestations of biliary tract malignancies.
Advanced Cancer Therapeutics
The investigator works with advanced solid tumors, developing and implementing novel treatment approaches for various cancer types.
- Early Phase Drug Development
- Innovative Treatment Modalities
- Complex Cancer Management
Their research encompasses dose-finding studies and the evaluation of emerging therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.